Barinthus Biotherapeutics - 53 Year Dividend History | BRNS
Historical dividend payout and yield for Barinthus Biotherapeutics (BRNS) since 1971. The current TTM dividend payout for Barinthus Biotherapeutics (BRNS) as of November 21, 2024 is $0.00. The current dividend yield for Barinthus Biotherapeutics as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.039B |
$0.001B |
|
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases. The company's product pipeline includes VTP-300, VTP-200, VTP-1000, VTP-850 and VTP-1100. Barinthus Biotherapeutics plc, formerly known as Vaccitech plc, is based in OXFORD, United Kingdom.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
